Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.45 |
| ▸ | CASP1 | P29466 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.37 |
| ▸ | THRB | P10828 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 4/20 | 0.36 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.33 |
| ▸ | TUBB | P07437 | 1/20 | 0.33 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29001084 | 1.00 | ALDH1A1 (0.45) | ALDH1A1TDP1CASP1MAPTCYP3A4 | |
| SCHEMBL30400387 | 0.88 | ALDH1A1 (0.44) | ALDH1A1TDP1CASP1MAPTCYP3A4 | |
| SCHEMBL4859496 | 0.81 | TDP1 (0.46) | ALDH1A1TDP1MAPTKMT2AMEN1 | |
| SCHEMBL28074392 | 0.78 | TSHR (0.43) | ALDH1A1TDP1CASP1MAPTCYP3A4 | |
| SCHEMBL28043404 | 0.77 | ALDH1A1 (0.63) | ALDH1A1TDP1MAPTCYP3A4KMT2A | |
| SCHEMBL8167265 | 0.76 | NR4A1 (0.61) | ALDH1A1TDP1CASP1MAPTCYP3A4 | |
| SCHEMBL31505704 | 0.76 | CA12 (0.47) | ALDH1A1TDP1MAPTCYP3A4KMT2A | |
| SCHEMBL30395505 | 0.76 | HDAC1 (0.42) | ALDH1A1TDP1MAPTKMT2AMEN1 | |
| SCHEMBL27932764 | 0.76 | CA12 (0.47) | ALDH1A1TDP1MAPTCYP3A4KMT2A | |
| SCHEMBL30078218 | 0.76 | NR4A1 (0.35) | ALDH1A1TDP1MAPTKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144903-A1 | RADIONUCLIDE-LABELED BORON-CONTAINING DRUG, AND PREPARATION AND USE THEREOF | Chengdu New Radiomedicine Technology Co., Ltd. (CN) | 2026-05-28 | — | — | US | claimed |
| EP-4667016-A1 | BORON-CONTAINING DRUG AND PREPARATION METHOD THEREFOR | Chengdu New Radiomedicine Technology Co., Ltd. (CN) | 2025-12-24 | — | — | EP | claimed |
| EP-4667020-A1 | RADIONUCLIDE-LABELED BORON-CONTAINING DRUG, AND PREPARATION AND USE THEREOF | Chengdu New Radiomedicine Technology Co., Ltd. (CN) | 2025-12-24 | — | — | EP | claimed |
| CN-116916755-A | Materials and methods for extending the shelf life of food products | JP实验室公司 | 2023-10-20 | — | — | CN | claimed |
| US-20260144903-A1 | RADIONUCLIDE-LABELED BORON-CONTAINING DRUG, AND PREPARATION AND USE THEREOF | Chengdu New Radiomedicine Technology Co., Ltd. (CN) | 2026-05-28 | — | — | US | disclosed |
| EP-4667016-A1 | BORON-CONTAINING DRUG AND PREPARATION METHOD THEREFOR | Chengdu New Radiomedicine Technology Co., Ltd. (CN) | 2025-12-24 | — | — | EP | disclosed |
| EP-4667020-A1 | RADIONUCLIDE-LABELED BORON-CONTAINING DRUG, AND PREPARATION AND USE THEREOF | Chengdu New Radiomedicine Technology Co., Ltd. (CN) | 2025-12-24 | — | — | EP | disclosed |
| CN-115160348-B | Method for directly borating aromatic C-H bond without metal catalysis under illumination | 中山大学 | 2024-06-21 | — | — | CN | disclosed |
| CN-116916755-A | Materials and methods for extending the shelf life of food products | JP实验室公司 | 2023-10-20 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144903-A1 | RADIONUCLIDE-LABELED BORON-CONTAINING DRUG, AND PREPARATION AND USE THEREOF | DBH, SLC39A11, GHRHR | ALDH1A1 1710/4885TDP1 3270/4885CASP1 3756/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.